N-SIDE is attending SCOPE Virtual Summit for Clinical Ops Executives.
SCOPE conference is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, advocacy organizations and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
The conference’s program is split in several tracks featuring best practice case studies relevant to clinical innovation and operations experts and those new to the field.
During the SCOPE Virtual Summit, N-SIDE is hosting a presentation in the Clinical Supply Data Technology for End-to-End Clinical Supply Management track. The presentation lead by Amaury Jeandrain, Head of Life Sciences Solutions Adoption at N-SIDE, is scheduled on March 2 at 11.15AM ET (5.15PM CET). Amaury will be discussing the following topic:
Accelerate time to market thanks to end-to-end clinical supply optimization
If they become a bottleneck, supply chain, manufacturing or budgets can delay clinical trials and slow down research. With an experience of over 10.000 optimized trials and programs, N-SIDE shares a path towards faster commercialization, through measurable drug waste and budget reductions enabled by end-to-end clinical supply chain optimization.
Key takeaways from the presentation:
- Discover how to avoid supply, manufacturing or budget bottlenecks in your clinical trials pipeline
- Learn how end-to-end optimization helps reduce drug waste by a guaranteed 20-60% on a program level
- Learn about innovative ways to reallocate capacity, drug and budgets towards acceleration of research
- Follow a case study illustrating how end-to-end optimization helps accelerate recruitment, initiate trials earlier or accelerate the start of new programs
Meet our speaker
Unable to attend? Learn more about the topic in our white paper!
Discover our blogpost on “Accelerate time to market with Clinical Supply Optimization” and download our related white paper to learn more about the benefits of optimizing your end-to-end clinical trial supply chain.